cIAP1 localizes to the nuclear compartment and modulates the cell cycle

Cancer Research

Volumn 65, Issue 1, 2005, Pages 210-218

  Samuel, Temesgen ^a   Okada, Kazuya ^a,b   Hyer, Marc ^a   Welsh, Kate ^a   Zapata, Juan M ^a   Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

^b NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE INHIBITOR; ETOPOSIDE; INHIBITOR OF APOPTOSIS PROTEIN; NOCODAZOLE; PACLITAXEL; PROTEIN CIAP1; STAUROSPORINE; SURVIVIN; UNCLASSIFIED DRUG;

ANAPHASE; ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL DIVISION; CELL FRACTIONATION; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; MICROTUBULE; MITOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TELOPHASE;

APOPTOSIS; CELL CYCLE; CELL DIVISION; CELL FRACTIONATION; CELL LINE, TUMOR; CELL NUCLEUS; HELA CELLS; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; MITOSIS; PROTEINS; REFERENCE VALUES;

EID: 11244322265     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Salvesen GS, Duckett CS. IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 2002;3:401-10.
2. Liston P, Fong WG, Korneluk RG. The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 2003;22:8568-80.
3. Reed JC, Doctor KS, Godzik A. The domains of apoptosis: a genomics perspective. Sci STKE 2004;2004:RE9 1-29.
4. Deveraux QL, Reed JC. IAP family proteins-suppressors of apoptosis. Genes Dev 1999;13:239-52.
5. Deveraux QL, Roy N, Stennicke HR, et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 1998;17:2215-23.
6. Deveraux QL, Takahashi R, Salvesen GS, Reed JC. X-linked IAP is a direct inhibitor of cell death proteases. Nature 1997;388:300-4.
7. Wilkinson JC, Cepero E, Boise LH, Duckett CS. Upstream regulatory role for XIAP in receptor-mediated apoptosis. Mol Cell Biol 2004;24:7003-14.
8. Reffey SB, Wurthner JU, Parks T, Roberts AB, Duckett CS. X-linked inhibitor of apoptosis protein functions as a cofactor in transforming growth factor-β signaling. J Biol Chem 2001;276:26542-9.
9. Sanna MG, Duckett CS, Richter BW, Thompson CB, Ulevitch RJ. Selective activation of JNK1 is necessary for the anti-apoptotic activity of hILP. Proc Natl Acad Sci U S A 1998;95:6015-20.
10. Sanna MG, de Silva Correia J, Ducrey O, et al. IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition. Mol Cell Biol 2002;22:1754-66.
11. Sanna MG, Correia JS, Luo Y, et al. ILPIP, a novel antiapoptotic protein that enhances XIAP-mediated activation of JNK1 and protection against apoptosis. J Biol Chem 2002;277:30454-62.
12. Yamaguchi K, Nagai S, Ninomiya-Tsuji J, et al. XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway. EMBO J 1999;18:179-87.
13. Hofer-Warbinek R, Schmid JA, Stehlik C, et al. Activation of NF-κB by XIAP, the X chromosome-linked inhibitor of apoptosis, in endothelial cells involves TAK1. J Biol Chem 2000;275:22064-8.
14. Roy N, Deveraux QL, Takashashi R, Salvesen GS, Reed JC. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 1997;16:6914-25.
15. Rothe M, Pan M-G, Henzel WJ, Ayres TM, Goeddel DV. The TNTR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 1995;83:1243-52.
16. Li X, Yang Y, Ashwell JD. TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 2002;416:345-9.
17. Altieri DC. Cytokinesis, apoptosis and Survivin: three for tango? Cell Death Differ 2001;8:4-5.
18. Chen J, Jin S, Tahir SK, et al. Survivin enhances aurora-B kinase activity and localizes aurora-B in human cells. J Biol Chem 2003;278:486-90.
19. Adams RR, Carmena M, Earnshaw WC. Chromosomal passengers and the (aurora) ABCs of mitosis. Trends Cell Biol 2001;11:49-54.
20. Bolton MA, Lan W, Powers SE, et al. Aurora B kinase exists in a complex with Survivin and INCENP and its activity is stimulated by Survivin binding and phosphorylation. Mol Biol Cell 2002;13:3064-77.
21. Uren AG, Wong L, Pakusch M, et al. Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr Biol 2000;10:1319-28.
22. Wheatley SP, Carvalho A, Vanarelli P, Earnshaw WC. INCENP is required for proper targeting of Survivin to the centromeres and the anaphase during mitosis. Curr Biol 2001;11:886-90.
23. Gassmann B, Carvalho A, Henzing AJ, et al. Borealin: a novel chromosomal passenger required for stability of the bipolar mitotic spindle. J Cell Biol 2004;166:179-91.
24. Marusawa H, Matsuzawa S-I, Welsh K, et al. HBXIP functions as a cofactor of Survivin in apoptosis suppression. EMBO J 2003;22:2729-40.
25. Dohi T, Okada K, Xia F, et al. An IAP-IAP complex inhibits apoptosis. J Biol Chem 2004;279:34087-90.
26. O'Connor DS, Grossman D, Li F, et al. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of Survivin. Proc Natl Acad Sci U S A 2000;97:13103-7.
27. Reed JC, Bischoff JR. BIRinging chromosomes through cell division-and Survivin the experience. Cell 2000;102:545-8.
28. Altieri DC. Survivin and apoptosis control. Adv Cancer Res 2003;88:31-52.
29. Li F. Survivin study: what is the next wave? J Cell Physiol 2003;197:8-29.
30. Altieri DC. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 2003;22:8581-9.
31. Reed JC. The Survivin saga goes in vivo. J Clin Invest 2001;108:965-9.
32. Liston P, Fong WG, Kelly NL, et al. Identification of XAF1 as an antagonist of XIAP anti-caspase activity. Nat Cell Biol 2001;3:128-33.
33. Ekedahl J, Joseph B, Grigoriev MY, et al. Expression of inhibitor of apoptosis proteins in small- and non-small-cell lung carcinoma cells. Exp Cell Res 2002;279:277-90.
34. Ponnelle T, Chapusot C, Martin L, et al. Subcellular expression of c-IAP1 and c-IAP2 in colorectal cancers: relationships with clinicopathological features and prognosis. Pathol Res Pract 2003;199:723-31.
35. McEleny KR, Watson RW, Coffey RN, O'Neill AJ, Fitzpatrick JM. Inhibitors of apoptosis proteins in prostate cancer cell lines. Prostate 2002;51:133-40.
36. Plenchette S, Cathelin S, Rebe C, et al. Translocation of the inhibitor of apoptosis protein c-IAP1 from the nucleus to the Golgi in hematopoietic cells undergoing differentiation: a nuclear export signal mediated event. Blood 2004;104:2035-43.
37. Krajewska M, Krajewski S, Turner B, et al. Elevated expression of inhibitor of apoptosis proteins (IAPs) in prostate cancer. Clin Cancer Res 2003;9:4914-25.
38. Terada Y. Role of chromosomal passenger complex in chromosome segregation and cytokinesis. Cell Struct Funct 2001;26:653-7.
39. Fortugno P, Wall NR, Giodini A, et al. Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function. J Cell Sci 2002;115:575-85.
40. Birnbaum MJ, Clem RJ, Miller LK. An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs. J Virol 1994;68:2521-8.
41. Vischioni B, Giaccone G, Span SW, Kruyt FA, Rodriguez JA, Nuclear shuttling and TRAF2-mediated retention in the cytoplasm regulate the subcellular localization of cIAP1 and cIAP2. Exp Cell Res 2004;298:535-48.
42. Abraham MC, Shaham S. Death without caspases, caspases without death. Trends Call Biol 2004;14:184-93.
43. Schimmer AD, Welsh K, Pinilla C, et al. Small-molecule antagonists of apoptosis-suppressor XIAP exhibit broad anti-tumor activity. Cancer Cell 2004;5:25-35.
44. Shin HJ, Baek KH, Jeon AH, et al. Dual roles of human BubR1, a mitotic checkpoint kinase, in the monitoring of chromosomal instability. Cancer Cell 2003;4:483-97.
45. Zhao J, Tenev T, Martins LM, Downward J, Lemoine NR. The ubiquitin-proteasome pathway regulates Survivin degradation in a cell cycle-dependent manner. J Cell Sci 2000;113:4363-71.
46. Clute P, Pines J. Temporal and spatial control of cyclin B1 destruction in metaphase. Nat Cell Biol 1999;1:82-7.
47. Whitfield ML, Sherlock G, Saldanha AJ, et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell 2002;13:1977-2000.
48. Li J, Feng Q, Kim J-M, et al. Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins. Endocrinology 2001;142:370-80.